1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Oct 17, 2024
2 Stavudol Paediatric Indication Approved For The Treatment Of Children Aged 3 Months And Older With Complicated Intra-Abdominal Infections Oct 09, 2024
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Nov 02, 2024
Read More Medical Cabozantinib In Combination With Atelizumab Works Well For Advanced Head And Neck Cancer Nov 12, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 03, 2024
